Ilastin-FT Nasal Spray is a combination intranasal medication containing Fluticasone Furoate (0.05% w/v), a potent corticosteroid, and Azelastine Hydrochloride (0.14% w/v), a selective histamine H1-receptor antagonist. This dual-action formulation is indicated for the management of symptoms associated with allergic rhinitis, including nasal congestion, sneezing, rhinorrhea, and nasal itching. Fluticasone Furoate exerts anti-inflammatory effects by inhibiting multiple types of inflammatory cells and mediators, thereby reducing nasal mucosal inflammation. Azelastine provides rapid symptomatic relief by blocking histamine receptors, which helps alleviate immediate hypersensitivity reactions. Ilastin-FT Nasal Spray is administered intranasally, allowing for targeted delivery to the nasal mucosa with minimal systemic absorption, enhancing efficacy while reducing systemic side effects. It is suitable for both seasonal and perennial allergic rhinitis in adults and adolescents aged 12 years and above. The recommended dosage is one spray per nostril twice daily or as directed by a healthcare professional. Common adverse effects may include nasal irritation, dryness, and a bitter taste. Patients should use this medication under medical supervision, especially those with a history of hypersensitivity to corticosteroids or antihistamines.